Thangaraj Jaya Lakshmi

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model

Sung-Hoon Jung, Manh-Cuong Vo, Je-Jung Lee, 2017, Oncotarget.

Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2018, Front. Immunol..

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Sung-Hoon Jung, 2019, Cancer Immunology, Immunotherapy.

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

J. Rhee, Je-Jung Lee, Hyun-ju Lee, 2018, Front. Immunol..

Cellular immunotherapy in multiple myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2019, The Korean journal of internal medicine.

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Translational oncology.

A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy

Saji Uthaman, I. Park, Je-Jung Lee, 2021, Cellular & Molecular Immunology.